Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.

Gynecologic and obstetric investigation - 1 Jan 2012

Maier Polyana S, Spritzer Poli Mara

Abstract excerpt

AIMS: To assess whether a single nucleotide polymorphism (SNP50) of the aromatase gene (CYP19) is associated with polycystic ovary syndrome (PCOS) phenotypes and to investigate the influence of this polymorphism on the response of PCOS to treatment with oral contraceptive pills (OCP). METHODS: 162 hirsute women were stratified into a classic PCOS group (hyperandrogenism, ovulatory dysfunction, c-PCOS) and an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgens
Share to Aromatase
Share to Blood Pressure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Contraceptives, Oral

Share to Hirsutism

Share to Hyperandrogenism

Share to Polycystic Ovary Syndrome

Source

Identifiers

PMID: 22889864
DOI: 10.1159/000339317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.PMID 22889864Read ↗

17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.Semantic proximity Read ↗

CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome.Semantic proximity Read ↗

Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.Semantic proximity Read ↗

Impact of CYP19A1 genetic variations on polycystic ovary syndrome: findings from a case-control study.Semantic proximity Read ↗

SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients.Semantic proximity Read ↗

Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.Semantic proximity Read ↗

Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.Semantic proximity Read ↗

Genetic variants in hormone-related genes and risk of breast cancer.Semantic proximity Read ↗

Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.Semantic proximity Read ↗

Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome.Semantic proximity Read ↗

No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.Semantic proximity Read ↗

Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.